Ubrogepant (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist being developed for the treatment of acute migraine.
Please choose the appropriate solvent according to the solubility of the product in different solvents to prepare the reserve solution; Once the solution is prepared, please store it separately to avoid product failure caused by repeated freezing and thawing.
Storage method and duration of the reserve liquid: for -80°C storage, please use within 6 months, for -20°C storage, please use within 1 month.
To increase solubility, heat the tube to 37 ° C and then shock it in an ultrasonic bath for a period of time.
Ubrogepant (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist being developed for the treatment of acute migraine.
Please choose the appropriate solvent according to the solubility of the product in different solvents to prepare the reserve solution; Once the solution is prepared, please store it separately to avoid product failure caused by repeated freezing and thawing.
Storage method and duration of the reserve liquid: for -80°C storage, please use within 6 months, for -20°C storage, please use within 1 month.
To increase solubility, heat the tube to 37 ° C and then shock it in an ultrasonic bath for a period of time.
Audited Supplier 
){kind=link}